Kvantify is a company that aims to democratize access to advanced computing technology, specifically High Performance Computing (HPC) and Quantum Computing, for businesses.

Kvantify

We solve the toughest computational challenges by leveraging the power of AI, quantum- and high-performance computing.

Quantum computing will revolutionize many aspects of computing, and complement High Performance Computing, in tackling the most valuable business problems in the world.

We can help your business harness the full potential of quantum and high-performance computers and deliver value to your business already today.

We are working closely with leading companies to develop solutions that address their most difficult computational challenges while focusing on areas where we first expect Quantum Computing to be valuable. This includes Life sciences, Financial Services, Logistics, and Telecommunication.

Are you ready to Quantify the Future?

Kvantify launches ground-breaking tool to revolutionize computational drug discovery 🔥

We are extremely proud to introduce the first outcome of our product development - a revolutionizing drug discovery tool. 

"Our new product is ground-breaking not least because it's the first commercial tool on the market that provides immediate value using our classical computer algorithm, while also being poised to deliver additional value as quantum computer hardware matures," says Hans Henrik H. Knudsen, CEO and Co-founder of Kvantify.

This is Kvantify’s first step towards revolutionizing computational drug discovery. 

Listen to our vision in the full launch video 👉 www.kvantify.com/koffee
Press Release 👉 https://lnkd.in/eSqa5k6H
Børsen article (Danish) 👉 https://lnkd.in/d6Xg5Hbz

Dive into the world of quantum computing with Nikolaj Thomas Zinner, co-founder of Kvantify, on the latest episode of 'The Superposition Guy’s Podcast' hosted by Yuval Boger 🎙️

Nikolaj, a physicist with a background in nuclear physics, shares his journey into quantum computing and the evolution of Kvantify's work with the technology.

In the podcast Nikolaj discusses the practical applications and challenges of quantum computing, offering valuable insights into its potential impact on various industries. From navigating complexities to addressing skepticism, Nikolaj provides a compelling perspective on the future of computing.

Listen and learn more about our mission as well answers to these questions:

❇️ What is the unique angle for Kvantify?

❇️ What kind of customers are you working with today?

❇️ How are you utilizing quantum algorithms for chemistry simulations?

❇️ What special kind of problems or unique solutions do you have in the optimisation space?

❇️ In terms of hardware, if you were a betting man or an investor, where would you put your money?

❇️ Will quantum progression be gradual or do you expect a quantum GPT moment for the general public?

Full episode on Apple Podcast 👉 https://lnkd.in/d7AgvUq2
or on Spotify 👉 https://lnkd.in/dWbKn8WG

Don't forget to follow 🖱️ Kvantify to stay updated about quantum computing application!

"You won’t find it difficult to prove that battles, campaigns, and even wars have been won or lost primarily because of logistics,” said General Dwight D. Eisenhower, the 34th POTUS.

That’s why one of NATO's must-win battles is the global quantum computing race. In brief, the one with the best logistics will have an enormous advantage. And a quantum computer has the potential to give you just that.

That’s why we at Kvantify have started a collaboration with Partisia. At Kvantify, we specialize in software for quantum computers; and we are, in all respects, one of the best companies in the world in our field. Partisia is a world-leading company when it comes to multiparty computation and encryption of data.

When combining these highly specialized companies, we end up with a whole that’s greater than the sum of its parts.

In brief – Kvantify will design the quantum algorithms, and Partisia will make sure that the exchange of information with one or more quantum computers happens in a secure way. And that is exactly what IT Watch has written an article about here 👉 https://lnkd.in/dj24FQuy

In this context, we would like to thank Security Tech Space Aarhus, without whom this project wouldn’t have been possible. Security Tech Space Aarhus was created roughly a year ago at the instigation of the mayor of Aarhus, Jacob Bundsgaard. So, thank you once again, Jacob!

#quantum #quantumcomputing #takethenextleap

Nikolaj Thomas Zinner  co-founder of Kvantify is my latest guest on the Supoerposition Guy's Podcast. Kvantify focuses on leveraging quantum computing for real-world applications, notably in optimization and computational drug discovery, through a unique algorithm, fast VQE, that efficiently calculates small molecules. Despite challenges in scaling and skepticism around variational algorithms, Nikolaj is optimistic about the field's potential. He describes a pragmatic approach to technology selection, anticipates a gradual advancement in quantum computing, potentially marked by breakthroughs in encryption or efficient problem-solving algorithms, and much more.

Listen here: https://hubs.ly/Q02t7mX60
Read the full transcript here: https://hubs.ly/Q02t7kdY0

Kvantify sets new record in collaboration with biotech- and enzyme giant Novonesis (former Novozymes): This is a world’s first on a quantum computer 🌍

We are proud to announce that Kvantify has made the world's FIRST calculation of enzymatic reactions on a quantum computer, well ahead of previous achievements done in our field. 

"𝘛𝘩𝘪𝘴 𝘤𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘰𝘯 𝘴𝘩𝘰𝘸𝘴 𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘮𝘢𝘯𝘺 𝘰𝘱𝘱𝘰𝘳𝘵𝘶𝘯𝘪𝘵𝘪𝘦𝘴 𝘧𝘰𝘳 𝘲𝘶𝘢𝘯𝘵𝘶𝘮 𝘤𝘰𝘮𝘱𝘶𝘵𝘪𝘯𝘨 𝘪𝘯 𝘵𝘩𝘦 𝘣𝘪𝘰𝘵𝘦𝘤𝘩 𝘢𝘯𝘥 𝘱𝘩𝘢𝘳𝘮𝘢 𝘪𝘯𝘥𝘶𝘴𝘵𝘳𝘺, 𝘢𝘯𝘥 𝘸𝘦 𝘢𝘳𝘦 𝘦𝘹𝘵𝘳𝘦𝘮𝘦𝘭𝘺 𝘱𝘭𝘦𝘢𝘴𝘦𝘥 𝘵𝘩𝘢𝘵 𝘕𝘰𝘷𝘰𝘯𝘦𝘴𝘪𝘴 𝘴𝘦𝘦𝘴 𝘵𝘩𝘦 𝘱𝘰𝘵𝘦𝘯𝘵𝘪𝘢𝘭 𝘰𝘧 𝘵𝘩𝘦 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺," says Hans Henrik H. Knudsen, Co-Founder, and CEO of Kvantify. 

The breakthrough shows that our methods have the potential to revolutionize scientific research by significantly reducing the time and resources required for complex experiments. For this historic calculation, we utilized the enzyme carbonic anhydrase, which plays a vital role in various biological processes such as regulating blood pH and facilitating CO2 transport. Additionally, its industrial applications include CO2 capture.

𝙒𝙖𝙣𝙩 𝙩𝙤 𝙡𝙚𝙖𝙧𝙣 𝙢𝙤𝙧𝙚? read on below and follow us at Kvantify to get updated. We will share more details, results and of course the scientific publication. 

Full press release 👉 https://lnkd.in/damub2zK
Newspaper article 👉 https://lnkd.in/dfPkRTjG

What sets Kvantify apart in computational drug discovery?

The short answer is our incorporation of novel physics-based modelling methods. We operate in the span from Hit Identification to Lead Optimization.

Our approach aims to expedite the refinement process from thousands of candidate compounds to single digit leads, offering unparalleled precision and speed. This complements existing technologies utilized for target identification and screening millions of compounds, thereby reducing drug discovery time significantly.

Our vision is to develop the premier platform for computational drug discovery, leveraging quantum technology. Curious? Take a look at our webpage: www.kvantify.com/koffee

Oh, and we’re proud to say that we are also endorsed by the European Innovation Council and SMEs Executive Agency (EISMEA) 🚀

Delving deeper into the tech that powers our new unbinding kinetics tool 🧬

This is for you in #biotech and #pharma who are pioneering the future of drug discovery, as well as anyone interested in our enabling technologies. In our latest video, we elaborate on the reasoning and approach for Kvantify koffee, the groundbreaking new product from our drug discovery platform. 

Join Nils Anton Berglund, our Head of Strategic Alliances, as he navigates the technical intricacies. This session is tailored to give you a view of how we are advancing drug discovery processes, making them as quick and efficient as brewing your morning coffee.

If we piqued your curiosity, don't hesitate to reach out 📨 𝗰𝗼𝗻𝘁𝗮𝗰𝘁@𝗸𝘃𝗮𝗻𝘁𝗶𝗳𝘆.𝗰𝗼𝗺 or hit the follow button 🖱️ to stay updated on Kvantify 

Full video and details here 👉 www.kvantify.com/koffee

Optimizing drug discovery pipelines, in the time it takes to brew a cup of coffee.

Listen to Christina Krogsgård Nielsen, Head of Products & Strategy at Kvantify, to discover our vision for quantum-enhanced computational drug discovery, and learn how we approach our long-term objective of enabling and optimizing the use of quantum computing, with the opportunity to provide value to businesses, already today.

Visit our webpage for the full video and details about our unbinding kinetics tool 👉 www.kvantify.com/koffee

𝙉𝙚𝙬 𝙗𝙡𝙤𝙜𝙥𝙤𝙨𝙩 on why AI and quantum computing make such great friends 👉

Link: https://lnkd.in/dhcGCzmC

At Kvantify we just released our first drug discovery product, koffee, which is a unique and novel computational calculation tool for fast and accurate drug discovery. Simply put, koffee can rank for how long drug molecules interact with their targets, a key aspect in understanding their action at the molecular level.

However, this is only the 𝗶𝗻𝗶𝘁𝗶𝗮𝗹 𝘀𝘁𝗲𝗽 𝗶𝗻 𝗼𝘂𝗿 𝗯𝗿𝗼𝗮𝗱𝗲𝗿 𝘃𝗶𝘀𝗶𝗼𝗻 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗰𝗼𝗺𝗽𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗱𝗿𝘂𝗴 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆. Ahead lies a road where we will see artificial Intelligence, physics-based simulation, and quantum computation coming together in a bigger picture.

By integrating these methods and leveraging their respective strengths, while acknowledging their limitations, you could create a significantly more effective tool as quantum computing hardware progressively advances. 

𝗕𝘂𝘁 𝗵𝗼𝘄 𝗶𝘀 𝘁𝗵𝗮𝘁 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲? Computational biology specialist at Kvantify Mikael Hvidtfeldt Christensen has quite interesting insights on that ☝️

Metric
Company Name	Kvantify
Symbol
MSH ID	COM:KVANTIFY
Market	PRIVATE
Sector	Technology
Industry	Quantum Computing and HPC Software Solutions
Country	DK
Stage	Seed
Employee Count	63
Website	kvantify.com
LinkedIn	kvantify
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital	10.74M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:KVANTIFY

Kvantify

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue